Your browser doesn't support javascript.
loading
Predictive factors of clinical outcomes in patients with COVID-19 treated with tocilizumab: A monocentric retrospective analysis.
Cassone, Giulia; Dolci, Giovanni; Besutti, Giulia; Braglia, Luca; Pavone, Paolo; Corsini, Romina; Sampaolesi, Fabio; Iotti, Valentina; Teopompi, Elisabetta; Massari, Marco; Fontana, Matteo; Ghidoni, Giulia; Matei, Anaflorina; Croci, Stefania; Negri, Emanuele Alberto; Costantini, Massimo; Facciolongo, Nicola; Salvarani, Carlo.
Affiliation
  • Cassone G; Rheumatology Unit, IRCCS Arcispedale Santa Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Dolci G; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
  • Besutti G; Infectious Disease Unit, University of Modena and Reggio Emilia, Modena, Italy.
  • Braglia L; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
  • Pavone P; Radiology Unit, Department of Imaging and Laboratory Medicine, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Corsini R; Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Sampaolesi F; Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Iotti V; Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Teopompi E; Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Massari M; Radiology Unit, Department of Imaging and Laboratory Medicine, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Fontana M; SOC Internistica Multidisciplinare, Ospedale Civile Guastalla, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Ghidoni G; Infectious Disease Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Matei A; Pneumology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Croci S; Pneumology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Negri EA; Department of Anesthesia and Intensive Care, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Costantini M; Clinical Immunology, Allergy and Advanced Biotechnologies Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Facciolongo N; High Intensity Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
  • Salvarani C; Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
PLoS One ; 17(1): e0262908, 2022.
Article in En | MEDLINE | ID: mdl-35081151
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Italy Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Guideline / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Italy Country of publication: United States